Target intelligence / Profile preview

alpha-1,3-glucan

Molecular classification
Other
01

Overview

alpha-1,3-glucan is a critical exopolysaccharide component of the extracellular polymeric substance (EPS) matrix in bacterial biofilms, most notably in dental plaque formed by Streptococcus mutans [2, 10]. Synthesized from dietary sucrose by extracellular glucosyltransferases, this water-insoluble polymer provides the essential structural framework and adhesive properties required for biofilm stability and attachment to tooth surfaces [7, 13]. Beyond its structural role, alpha-1,3-glucan acts as a protective barrier that sequesters antimicrobial agents and shields bacteria from host immune responses, contributing significantly to the high antibiotic resistance observed in biofilm-associated infections [8, 15]. In the context of oral health, the accumulation of alpha-1,3-glucan facilitates the localized production of organic acids, leading to enamel demineralization and the development of dental caries [4, 17]. Therapeutic strategies targeting this molecule involve the use of glucanohydrolases, such as mutanase (alpha-1,3-glucanase), which enzymatically hydrolyze the alpha-1,3-glycosidic bonds to destabilize the biofilm architecture [5, 11]. This non-biocidal approach promotes biofilm dispersal and enhances the efficacy of co-administered antimicrobial agents without indiscriminately killing the commensal oral microbiota [2, 3].

Other names
MutanWater-insoluble glucanWIG(1->3)-alpha-D-glucanalpha-1,3-linked glucan
02

Mechanism of action

Enzymatic hydrolysis of alpha-1,3-glycosidic bonds leading to biofilm matrix degradation and dispersal

03

Biological functions

Other
04

Disease associations

Infection
05

Safety considerations

Potential for oral microbiome dysbiosisEnzyme stability in oral care formulationsImmunogenicity of fungal-derived enzymes
06

Interacting drugs

Mutanase

1 more in the full profile.

07

Biomarkers

Biofilm massWater-insoluble glucan concentrationStreptococcus mutans levels

Beyond the preview

Go deeper on alpha-1,3-glucan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on alpha-1,3-glucan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call